Drug Shortage Report for MAR-GABAPENTIN
| Report ID | 30475 |
| Drug Identification Number | 02391473 |
| Brand name | MAR-GABAPENTIN |
| Common or Proper name | MAR-Gabapentin |
| Company Name | MARCAN PHARMACEUTICALS INC |
| Market Status | DORMANT |
| Active Ingredient(s) | GABAPENTIN |
| Strength(s) | 100MG |
| Dosage form(s) | CAPSULE |
| Route of administration | ORAL |
| Packaging size | 100 Capsule |
| ATC code | N03AX |
| ATC description | ANTIEPILEPTICS |
| Reason for shortage | Delay in shipping of the drug. |
| Anticipated start date | 2017-09-10 |
| Actual start date | 2017-09-10 |
| Estimated end date | 2018-05-15 |
| Actual end date | 2018-04-24 |
| Shortage status | Resolved |
| Updated date | 2018-07-06 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 2 GURDWARA RD., SUITE 112 OTTAWA, ONTARIO CANADA K2E 1A2 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v7 | 2018-07-06 | French | Compare |
| v6 | 2018-07-06 | English | Compare |
| v5 | 2018-04-25 | English | Compare |
| v4 | 2018-04-24 | French | Compare |
| v3 | 2018-04-24 | English | Compare |
| v2 | 2017-11-23 | French | Compare |
| v1 | 2017-11-23 | English | Compare |
Showing 1 to 7 of 7